Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae

Antimicrob Agents Chemother. 2004 Feb;48(2):605-7. doi: 10.1128/AAC.48.2.605-607.2004.

Abstract

The in vitro activities of two investigational ketolides, cethromycin (formerly ABT-773) and telithromycin, were determined for a selected group of 312 Streptococcus pneumoniae isolates from a national surveillance program. The MIC of cethromycin at which 50% of the isolates were inhibited was 0.008 micro g/ml, and the MIC at which 90% of the isolates were inhibited was 0.06 micro g/ml; the corresponding values for telithromycin were </=0.015 and 0.25 micro g/ml, respectively. For six quinupristin-dalfopristin-resistant strains, the cethromycin MICs were 0.25 to 16 micro g/ml and the telithromycin MICs were 1 to 4 micro g/ml. However, there was only 0.3% resistance to telithromycin.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Bacterial
  • Erythromycin / analogs & derivatives
  • Erythromycin / pharmacology*
  • Genes, Bacterial / genetics
  • Humans
  • Ketolides*
  • Macrolides / pharmacology*
  • Microbial Sensitivity Tests
  • North America
  • Pneumococcal Infections / microbiology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Streptococcus pneumoniae / drug effects*
  • Streptococcus pneumoniae / genetics

Substances

  • Anti-Bacterial Agents
  • Ketolides
  • Macrolides
  • Erythromycin
  • cethromycin
  • telithromycin